Perelman School of Medicine

A scientist with a pipette and a test tube with a computer screen in the background.

Science behind genetic testing for identifying risk of opioid misuse remains unproven

A new report from researchers at the Perelman School of Medicine and Crescenz VA Medical Center has evaluated a genetic test for opioid use disorder that recently received pre-marketing approval by the FDA, finding that the genes comprising it do not accurately identify individuals likely to develop the disorder.

Developing a tiny anticancer weapon

Penn Medicine researchers have developed tumor-homing nanosized particles that trigger cancer cell self-destruction in preclinical tests.

Scientists holding a model of something (forthcoming)

Penn Center for Innovation celebrates 10 years

The University’s nexus for technology transfer supports researchers in their innovative efforts, from CAR T to mRNA advancements that have dramatically reshaped the world.

Five from Penn recognized with Presidential Early Career Award for Scientists and Engineers

The award honors federally funded early-career scientists.

Helping Korean Americans with end-of-life planning is her passion

Eunice Park-Clinton, a nurse case manager in the Hospital of the University of Pennsylvania’s Emergency Department, leads seminars for Korean-speaking families to understand end-of-life care, with funding from a Penn Medicine CARES grant.

Aaron Levy and students gathered around a table filled with images.

Through Literature of Care course, a curriculum of compassion

Literature of Care, a course offered every fall in the School of Arts & Sciences, explores medical humanities and the role storytelling plays in patient care.

Discovery links cellular structures to kidney cancer treatment outcomes

New research from Penn Medicine finds patterns in cells of tumors may guide personalized therapies for clear cell renal cell carcinoma.

Iahn Cajigas and Qasim Qureshi review data on a desktop computer.

Brain research could help patients with paralysis move again

Penn Medicine researchers are using machine learning to study the areas of the brain that control movement.

A pregnant person meeting with their doctor.

New tool puts reproductive risk for BRCA carriers into perspective

A team at Penn Medicine has created a resource to help inform reproductive counseling for cancer gene mutation carriers.

Judith Schaechter and Anjan Chatterjee looking at her stained glass installation.

Your brain on beauty

At the Penn Center for Neuroaesthetics, researchers explore what exactly the brain is doing when it experiences art, and what artists are doing when they create art out of their experiences.

Filters